U.S. markets closed

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
80.32+0.37 (+0.46%)
At close: 04:00PM EST
80.35 +0.03 (+0.04%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close79.95
Bid80.20 x 1200
Ask80.50 x 1300
Day's Range78.76 - 81.82
52 Week Range62.55 - 217.25
Avg. Volume4,107,410
Market Cap30.625B
Beta (5Y Monthly)1.62
PE Ratio (TTM)N/A
EPS (TTM)-9.23
Earnings DateFeb 21, 2024 - Feb 26, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est134.16
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
12% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for MRNA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Moderna, Inc.
    Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We CoverIn this edition, oil spike optimism loses steam for now; Dexus investors poised to befit from patience; mRNA pipeline to boost Moderna; and XPO, Kinder Morgan, and Asana.
    Fair Value
    Economic Moat
    11 hours agoMorningstar
View more